Dear UNPA Colleagues --
I am pleased to forward very useful and current information and risk management advice received from Tracie Belt, Vice President at Marsh & McLennan (a UNPA member). I attach Tracie's e-mail which includes a link to a coronavirus insights update as well as a report particularly important to risk managers and officers and directors with respect to liabilities rising out of COVID-19 risk management. We recommend both resources to you as highly informed and reliable advice.
Dear Colleagues --
With the continued disruption caused by the COVID-19 virus, virtually all of our natural product industry events have been affected. Knowing that everyone is trying to stay current on what is canceled, postponed, and what the reset dates are, we have collected as much of this key information as possible, including checking with our key MOU partners as well as directly with a number of the event organizers to develop this March 13 version which shows where things stand (attached). We will continue to monitor and update this calendar and will work toward sending you a weekly update.
Dear UNPA HE/C Committee Colleagues,
Due to a conflict with an AHPA Cannabis Committee call on Friday, we have rescheduled the UNPA HE/C Committee update for Monday, March 16. We apologize for any inconvenience. This webinar will be recorded if you’re unable to join us.
The Feb. 27 TraceGains’ webinar, “Coronavirus: How to avoid supply-chain disruptions," is now available for viewing and PPT download at the link below. This one-hour webinar features UNPA’s Loren Israelsen, who discusses the latest information about supply-chain disruption of Chinese ingredients, the impact of continued issues, including manufacturing, FSMA compliance and documentation, potential adulteration and shipping, and what we know about coronavirus as a health risk.
FDA has just submitted its much-awaited “Report in Response to Further Consolidated Appropriations Act, 2020,” cannabidiol (CBD) report to the Senate and House Appropriations Committees (enclosed here as an attachment), and Peter, Patricia and I wanted to give you our initial reaction as quickly as possible.
This report, to fulfill FDA’s requirement to provide an update on the agency’s evaluation of potential regulatory pathways for CBD products and efforts to gather data to support evaluation of a policy of enforcement discretion is disappointing but not unexpected. FDA continues to commit only to continued exploration of a regulatory pathway. It is clear that even after over a year of working on this, the agency is far from making a decision about whether or how to propose a regulatory pathway for dietary supplements containing CBD.
Take Two: The UNPA Virtual Members' Meeting
Join us for a webinar on Mar 11, 2020 at 11:00 AM MDT.
With the postponement of Expo West and the cancellation of our members' meeting, we will be holding a 1-hour webinar on March 11th. We are keen to update you on the following key issues :
UNPA 2020 Priorities
COVID-19 Insights on Supply Chain and Market Disruptions
Political and Election Update
The Staus of CBD/Hemp and a Regulatory Pathway
China Update from Daniel Mabey (still in "lockdown") presented by Loren Israelsen
Southwest College's Master of Science degree in Nutrition Business Leadership - UNPA Member Scholarship Program
Introduction of New Members
Upcoming Events (*possible effects of COVID-19)
Given the unusual circumstances, we hope you'll join us as we walk through the opportunities and uncertainties of the moment.
After registering, you will receive a confirmation email containing information about joining the webinar.
View System Requirements
CANCELLATION NOTICE FOR:
UNPA Members' Meeting
Date: Wednesday, March 4
Members' Meeting: 8:00 - 9:00 am
Open House and Meet & Greet: 9:00-10:00 am
Room: Avalon Ballroom, Anaheim Hilton & Towers Hotel
Dear Colleagues --
Please see the update below provided by Peter and Trish. Always a lot going on in Washington.
We appreciate all they are doing to keep us up to speed on this fast-moving issue.
I am pleased to send you this link to the registration site for the International Conference on the Science of Botanicals (ICSB) to be held at the University of Mississippi, March 30-April 2, 2020.
This is my FAVORITE event of the year and also the most important. This is the annual gathering of the global botanical industry, the U.S. FDA staff responsible for botanical dietary supplements and botanical drugs, the National Center for Natural Products Research (NCNPR) staff and faculty, and a battalion of world-class scientists & researchers who share a common interest to advance the science, safety and use of botanicals.
...not to mention the lawn game olympics, the gracious hosting of the Ole Miss staff, and as much boiled shrimp, fried catfish and collard greens you can eat. I should also mention the infamous photo booth which is only discussed in hushed voices and darkened rooms. That is also not to be missed.
So, please join me and many of your colleagues at this year's ICSB. The data, again, is March 30-April 2, 2020. Be sure to reserve your hotel ASAP.
Dear Colleagues --
Today we received and now forward a note from Charlie Rast at the U.S. Department of Commerce/International Trade Administration. We have known and worked with Charlie for many years. He has forwarded the announcement of complimentary programs and exhibitor consultations that will be available through the U.S. Commercial Service at Expo West.
For those of you interested in international export, we highly recommend signing up for one-on-one consultations for the listed countries of interest as well as the other education programs being offered.
UNPA works very closely with the USCS and has great respect for their work and results.